drugset / Trial / NCT01507402
A Study to Assess the Safety and Tolerability of Single Ascending Doses of REGN1033(SAR391786)
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, single ascending dose study to assess the safety and tolerability of Intravenous (IV) and Subcutaneous (SC) REGN1033(SAR391786) in healthy volunteers.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trevogrumab | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.